Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for STOK

Stock Name	Stoke Therapeutics Inc
Ticker	STOK(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US86150R1077
LEI	549300RD25SS2DIJHJ67

Show aggregate STOK holdings

News associated with STOK

Notable Wednesday Option Activity: AAPL, STOK, Z: Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Apple Inc (Symbol: AAPL), where a total volume of 543,181 contracts has been traded thus far today, a contract volume which is representative of approximately 54 - 2025-09-17 16:17:22
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?: (RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a battle between our patience and our impulses." - 2025-09-15 03:55:16
Analysts Set Stoke Therapeutics, Inc. (NASDAQ:STOK) PT at $25.57: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price among […] - 2025-08-22 03:12:53
Stoke Therapeutics (NASDAQ:STOK) Shares Gap Up on Better-Than-Expected Earnings: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s share price gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $13.53, but opened at $14.89. Stoke Therapeutics shares last traded at $15.14, with a volume of 236,029 shares changing hands. The company reported ($0.40) […] - 2025-08-15 02:34:48
40,181 Shares in Stoke Therapeutics, Inc. (NASDAQ:STOK) Acquired by XTX Topco Ltd: XTX Topco Ltd purchased a new stake in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) during the 1st quarter, HoldingsChannel reports. The fund purchased 40,181 shares of the company’s stock, valued at approximately $267,000. Other large investors have also recently bought and sold shares of the company. RTW Investments LP raised its position in Stoke […] - 2025-08-12 04:30:53
Brokerages Set Stoke Therapeutics, Inc. (NASDAQ:STOK) Target Price at $25.80: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has received an average recommendation of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year price […] - 2025-07-28 02:30:54
Stoke Therapeutics (NASDAQ:STOK) Shares Gap Up – Here’s What Happened: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $12.35, but opened at $12.93. Stoke Therapeutics shares last traded at $12.75, with a volume of 96,492 shares traded. Wall Street Analyst Weigh In A number of research analysts have recently weighed […] - 2025-07-20 05:22:59
Alps Advisors Inc. Sells 2,940 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK): Alps Advisors Inc. decreased its stake in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 6.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,890 shares of the company’s stock after selling 2,940 shares during the period. Alps Advisors Inc.’s holdings […] - 2025-07-18 05:21:01
Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Rating of “Buy” by Brokerages: Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have been assigned an average recommendation of “Buy” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average […] - 2025-06-30 02:34:50
Assenagon Asset Management S.A. Cuts Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK): Assenagon Asset Management S.A. lowered its position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 29.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 959,603 shares of the company’s stock after selling 391,322 shares during the period. Assenagon Asset Management S.A.’s holdings in Stoke Therapeutics were worth $6,381,000 as of […] - 2025-06-15 05:44:52
Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Sold by BNP Paribas Financial Markets: BNP Paribas Financial Markets decreased its position in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 94.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,422 shares of the company’s stock after selling 71,732 shares during the quarter. BNP Paribas Financial […] - 2025-06-04 05:14:48
Legal & General Group Plc Has $390,000 Stock Position in Stoke Therapeutics, Inc. (NASDAQ:STOK): Legal & General Group Plc trimmed its position in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 5.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,347 shares of the company’s stock after selling 2,139 shares during the quarter. Legal & General […] - 2025-05-01 04:42:53
Renaissance Technologies LLC Buys Shares of 129,043 Stoke Therapeutics, Inc. (NASDAQ:STOK): Renaissance Technologies LLC purchased a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 129,043 shares of the company’s stock, valued at approximately $1,423,000. Other large investors have […] - 2025-04-29 04:58:53
Stoke Therapeutics (NASDAQ:STOK) Receives “Buy” Rating from Needham & Company LLC: Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $22.00 price objective on the stock. Needham & Company LLC’s price objective suggests a potential upside of 237.42% from […] - 2025-04-11 04:46:50
HC Wainwright Reaffirms “Buy” Rating for Stoke Therapeutics (NASDAQ:STOK): Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $47.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 464.23% from the stock’s previous close. HC […] - 2025-03-21 04:25:10
Stoke Therapeutics (NASDAQ:STOK) Earns Buy Rating from Needham & Company LLC: Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They presently have a $22.00 target price on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 166.34% from the stock’s […] - 2025-03-20 04:44:48
Brokerages Set Stoke Therapeutics, Inc. (NASDAQ:STOK) Target Price at $23.00: Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have earned an average rating of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy […] - 2025-02-28 04:26:56
Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives $21.29 Average Target Price from Brokerages: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The […] - 2025-02-03 04:24:54

iShares Healthcare Innovation UCITS ETF USD (Acc) STOK holdings

Date	Number of STOK Shares Held	Base Market Value of STOK Shares	Local Market Value of STOK Shares	Change in STOK Base Value	Current Price per STOK Share Held	Previous Price per STOK Share Held
2025-11-11 (Tuesday)	66,155	USD 1,661,152	USD 1,661,152	USD 181,265	USD 25.11	USD 22.37
2025-11-10 (Monday)	66,155	USD 1,479,887	USD 1,479,887	USD -32,416	USD 22.37	USD 22.86
2025-11-07 (Friday)	66,155	USD 1,512,303	USD 1,512,303	USD 25,800	USD 22.86	USD 22.47
2025-11-06 (Thursday)	66,155	USD 1,486,503	USD 1,486,503	USD -23,154	USD 22.47	USD 22.82
2025-11-05 (Wednesday)	66,155	USD 1,509,657	USD 1,509,657	USD -166,711	USD 22.82	USD 25.34
2025-11-04 (Tuesday)	66,155	USD 1,676,368	USD 1,676,368	USD -50,278	USD 25.34	USD 26.1
2025-11-03 (Monday)	66,155	USD 1,726,646	USD 1,726,646	USD -260,650	USD 26.1	USD 30.04
2025-10-31 (Friday)	66,155	USD 1,987,296	USD 1,987,296	USD -109,818	USD 30.04	USD 31.7
2025-10-30 (Thursday)	66,155	USD 2,097,114	USD 2,097,114	USD 19,185	USD 31.7	USD 31.41
2025-10-29 (Wednesday)	66,155	USD 2,077,929	USD 2,077,929	USD -14,554	USD 31.41	USD 31.63
2025-10-28 (Tuesday)	66,155	USD 2,092,483	USD 2,092,483	USD -90,632	USD 31.63	USD 33
2025-10-27 (Monday)	66,155	USD 2,183,115	USD 2,183,115	USD 47,632	USD 33	USD 32.28

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of STOK by Blackrock for IE00BYZK4776

Show aggregate share trades of STOK

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -562 32.280 32.460 32.442 USD -18,232 12.54 Loss of -11,182 on sale
2025-09-11 BUY 283 23.880 24.000 23.988 USD 6,789 10.63
2025-07-08 SELL -283 12.010 12.250 12.226 USD -3,460 10.18 Loss of -579 on sale
2025-06-24 SELL -289 11.510 12.140 12.077 USD -3,490 10.09 Loss of -575 on sale
2025-06-23 SELL -289 11.590 11.761 11.744 USD -3,394 10.08 Loss of -482 on sale
2025-06-20 BUY 34,245 11.580 11.960 11.922 USD 408,269 10.07
2025-06-11 SELL -145 11.500 11.810 11.779 USD -1,708 9.98 Loss of -261 on sale
2025-05-30 SELL -146 9.540 9.700 9.684 USD -1,414 9.93 Profit of 36 on sale
2025-05-21 BUY 146 9.480 10.060 10.002 USD 1,460 9.96
2025-05-14 SELL -870 8.990 9.100 9.089 USD -7,907 9.98 Profit of 772 on sale
2025-04-30 SELL -144 9.760 9.880 9.868 USD -1,421 10.04 Profit of 25 on sale
2025-04-28 SELL -144 9.470 9.890 9.848 USD -1,418 10.05 Profit of 29 on sale
2025-04-25 SELL -144 9.760 9.906 9.891 USD -1,424 10.05 Profit of 23 on sale
2025-04-11 SELL -924 7.020 7.130 7.119 USD -6,578 10.21 Profit of 2,856 on sale
2025-04-08 SELL -459 5.900 6.340 6.296 USD -2,890 10.35 Profit of 1,859 on sale
2025-04-07 SELL -308 6.010 6.170 6.154 USD -1,895 10.40 Profit of 1,306 on sale
2025-03-31 SELL -302 6.650 7.080 7.037 USD -2,125 10.59 Profit of 1,074 on sale
2025-03-21 SELL -294 8.150 8.350 8.330 USD -2,449 10.82 Profit of 732 on sale
2025-03-12 SELL -155 8.520 8.590 8.583 USD -1,330 11.05 Profit of 383 on sale
2025-02-28 SELL -155 7.850 8.134 8.106 USD -1,256 11.47 Profit of 521 on sale
2025-02-25 BUY 155 8.250 8.630 8.592 USD 1,332 11.64
2025-02-20 SELL -154 8.740 9.330 9.271 USD -1,428 11.81 Profit of 390 on sale
2025-02-19 BUY 304 9.300 9.940 9.876 USD 3,002 11.85
2025-02-18 BUY 152 9.710 11.110 10.970 USD 1,667 11.89
2024-12-30 SELL -287 10.800 11.090 11.061 USD -3,175 12.42 Profit of 390 on sale
2024-12-06 SELL -141 13.270 13.450 13.432 USD -1,894 12.32 Loss of -157 on sale
2024-12-04 SELL -141 12.810 13.500 13.431 USD -1,894 12.29 Loss of -160 on sale
2024-12-03 SELL -284 11.430 12.230 12.150 USD -3,451 12.32 Profit of 50 on sale
2024-11-21 SELL -150 11.270 11.730 11.684 USD -1,753 12.55 Profit of 130 on sale
2024-11-20 SELL -155 11.310 11.635 11.603 USD -1,798 12.62 Profit of 158 on sale
2024-11-19 SELL -155 11.610 11.850 11.826 USD -1,833 12.68 Profit of 133 on sale
2024-11-18 SELL -576 11.880 12.600 12.528 USD -7,216 12.73 Profit of 118 on sale
2024-11-12 SELL -144 13.620 13.770 13.755 USD -1,981 12.67 Loss of -156 on sale
2024-11-07 SELL -144 13.270 13.750 13.702 USD -1,973 12.53 Loss of -168 on sale
2024-11-05 SELL -288 13.050 13.090 13.086 USD -3,769 12.42 Loss of -191 on sale
2024-10-28 SELL -145 12.310 12.325 12.323 USD -1,787 12.22 Loss of -14 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-562	32.280	32.460	32.442	USD -18,232	12.54 Loss of -11,182 on sale
2025-09-11	BUY	283	23.880	24.000	23.988	USD 6,789	10.63
2025-07-08	SELL	-283	12.010	12.250	12.226	USD -3,460	10.18 Loss of -579 on sale
2025-06-24	SELL	-289	11.510	12.140	12.077	USD -3,490	10.09 Loss of -575 on sale
2025-06-23	SELL	-289	11.590	11.761	11.744	USD -3,394	10.08 Loss of -482 on sale
2025-06-20	BUY	34,245	11.580	11.960	11.922	USD 408,269	10.07
2025-06-11	SELL	-145	11.500	11.810	11.779	USD -1,708	9.98 Loss of -261 on sale
2025-05-30	SELL	-146	9.540	9.700	9.684	USD -1,414	9.93 Profit of 36 on sale
2025-05-21	BUY	146	9.480	10.060	10.002	USD 1,460	9.96
2025-05-14	SELL	-870	8.990	9.100	9.089	USD -7,907	9.98 Profit of 772 on sale
2025-04-30	SELL	-144	9.760	9.880	9.868	USD -1,421	10.04 Profit of 25 on sale
2025-04-28	SELL	-144	9.470	9.890	9.848	USD -1,418	10.05 Profit of 29 on sale
2025-04-25	SELL	-144	9.760	9.906	9.891	USD -1,424	10.05 Profit of 23 on sale
2025-04-11	SELL	-924	7.020	7.130	7.119	USD -6,578	10.21 Profit of 2,856 on sale
2025-04-08	SELL	-459	5.900	6.340	6.296	USD -2,890	10.35 Profit of 1,859 on sale
2025-04-07	SELL	-308	6.010	6.170	6.154	USD -1,895	10.40 Profit of 1,306 on sale
2025-03-31	SELL	-302	6.650	7.080	7.037	USD -2,125	10.59 Profit of 1,074 on sale
2025-03-21	SELL	-294	8.150	8.350	8.330	USD -2,449	10.82 Profit of 732 on sale
2025-03-12	SELL	-155	8.520	8.590	8.583	USD -1,330	11.05 Profit of 383 on sale
2025-02-28	SELL	-155	7.850	8.134	8.106	USD -1,256	11.47 Profit of 521 on sale
2025-02-25	BUY	155	8.250	8.630	8.592	USD 1,332	11.64
2025-02-20	SELL	-154	8.740	9.330	9.271	USD -1,428	11.81 Profit of 390 on sale
2025-02-19	BUY	304	9.300	9.940	9.876	USD 3,002	11.85
2025-02-18	BUY	152	9.710	11.110	10.970	USD 1,667	11.89
2024-12-30	SELL	-287	10.800	11.090	11.061	USD -3,175	12.42 Profit of 390 on sale
2024-12-06	SELL	-141	13.270	13.450	13.432	USD -1,894	12.32 Loss of -157 on sale
2024-12-04	SELL	-141	12.810	13.500	13.431	USD -1,894	12.29 Loss of -160 on sale
2024-12-03	SELL	-284	11.430	12.230	12.150	USD -3,451	12.32 Profit of 50 on sale
2024-11-21	SELL	-150	11.270	11.730	11.684	USD -1,753	12.55 Profit of 130 on sale
2024-11-20	SELL	-155	11.310	11.635	11.603	USD -1,798	12.62 Profit of 158 on sale
2024-11-19	SELL	-155	11.610	11.850	11.826	USD -1,833	12.68 Profit of 133 on sale
2024-11-18	SELL	-576	11.880	12.600	12.528	USD -7,216	12.73 Profit of 118 on sale
2024-11-12	SELL	-144	13.620	13.770	13.755	USD -1,981	12.67 Loss of -156 on sale
2024-11-07	SELL	-144	13.270	13.750	13.702	USD -1,973	12.53 Loss of -168 on sale
2024-11-05	SELL	-288	13.050	13.090	13.086	USD -3,769	12.42 Loss of -191 on sale
2024-10-28	SELL	-145	12.310	12.325	12.323	USD -1,787	12.22 Loss of -14 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of STOK

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	262,760	120	369,781	71.1%
2025-09-18	345,578	6,230	402,474	85.9%
2025-09-17	259,773	0	416,703	62.3%
2025-09-16	82,952	0	261,951	31.7%
2025-09-15	127,587	993	276,305	46.2%
2025-09-12	255,262	3,603	365,375	69.9%
2025-09-11	300,167	8,555	440,705	68.1%
2025-09-10	353,400	0	484,109	73.0%
2025-09-09	183,646	100	292,153	62.9%
2025-09-08	329,798	0	585,233	56.4%
2025-09-05	98,134	10	194,324	50.5%
2025-09-04	122,399	505	235,777	51.9%
2025-09-03	222,505	23	315,410	70.5%
2025-09-02	258,382	703	412,066	62.7%
2025-08-29	160,764	424	219,706	73.2%
2025-08-28	149,055	0	220,197	67.7%
2025-08-27	116,276	13,373	208,155	55.9%
2025-08-26	389,100	479	772,802	50.3%
2025-08-25	120,687	1,219	207,751	58.1%
2025-08-22	132,525	7,377	305,663	43.4%
2025-08-21	183,477	0	320,429	57.3%
2025-08-20	177,477	1,472	319,663	55.5%
2025-08-19	233,847	443	570,003	41.0%
2025-08-18	266,157	2,972	393,813	67.6%
2025-08-15	325,620	13,531	744,113	43.8%
2025-08-14	465,564	1,736	679,942	68.5%
2025-08-13	689,376	127	1,184,978	58.2%
2025-08-12	91,216	0	155,563	58.6%
2025-08-11	66,965	39	112,390	59.6%
2025-08-08	82,362	0	126,449	65.1%
2025-08-07	87,291	21	136,049	64.2%
2025-08-06	212,281	190	318,905	66.6%
2025-08-05	89,249	0	120,250	74.2%
2025-08-04	100,923	0	144,550	69.8%
2025-08-01	87,655	0	133,696	65.6%
2025-07-31	101,691	0	146,686	69.3%
2025-07-30	87,857	0	136,030	64.6%
2025-07-29	120,439	100	375,067	32.1%
2025-07-28	151,571	3,048	240,590	63.0%
2025-07-25	168,182	1,866	331,958	50.7%
2025-07-24	248,649	116	499,350	49.8%
2025-07-23	401,884	19	652,146	61.6%
2025-07-22	581,247	292	1,255,404	46.3%
2025-07-21	177,262	0	270,205	65.6%
2025-07-18	428,131	0	678,550	63.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE